Is Hashimoto's thyroiditis an autoimmune condition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Hashimoto's Thyroiditis an Autoimmune Condition?

Yes, Hashimoto's thyroiditis is definitively an autoimmune disease characterized by autoimmune-triggered lymphocytic infiltration and destruction of the thyroid gland. 1, 2, 3

Pathophysiology of Autoimmune Destruction

Hashimoto's thyroiditis represents the most common autoimmune endocrine disorder worldwide, with an annual incidence of 0.3-1.5 per 1000 people and affecting approximately 8% of the general population. 4 The disease is fundamentally autoimmune in nature, involving:

  • Loss of immunological tolerance leading to autoimmune attack on thyroid tissue through both humoral (antibody-mediated) and cellular (T-cell mediated) immunity. 3, 5

  • Lymphocytic infiltration, particularly T cells, with follicular destruction serving as the histological hallmark of the condition, ultimately leading to gradual thyroid atrophy and fibrosis. 5

  • Genetic predisposition involving specific HLA associations (HLA-DR/DQ alleles) that can be either predisposing or protective, combined with environmental triggers such as iodine supply, infections, and stress. 6, 2

Association with Other Autoimmune Conditions

The autoimmune nature of Hashimoto's is further confirmed by its frequent coexistence with other autoimmune disorders, demonstrating shared genetic predisposition and environmental triggers:

  • Type 1 diabetes mellitus, celiac disease, autoimmune hepatitis, systemic lupus erythematosus (2.2-3%), rheumatoid arthritis (2-4%), and Sjögren syndrome (2.8-7%) commonly occur alongside Hashimoto's thyroiditis. 7, 6

  • In patients with autoimmune hepatitis, autoimmune thyroid disease is the most common concurrent condition, affecting 10-23% of patients, with Hashimoto's specifically accounting for 10.2-14.1% of all concomitant autoimmune diseases. 8

  • Approximately 20-30% of patients with Hashimoto's have associated organ-specific or systemic autoimmune disorders. 5

Clinical Implications

Screening for additional autoimmune conditions is recommended in patients with Hashimoto's thyroiditis, particularly for the most common associations, with extended diagnostic screening conducted both at diagnosis and at regular intervals during follow-up. 7

Family history should be carefully evaluated as first-degree relatives of Hashimoto's patients have an increased risk of developing autoimmune diseases, reflecting the genetic component of autoimmune susceptibility. 7

References

Research

Hashimoto's thyroiditis in patients with normal thyroid-stimulating hormone levels.

Expert review of endocrinology & metabolism, 2012

Research

Pathogenesis Markers of Hashimoto's Disease-A Mini Review.

Frontiers in bioscience (Landmark edition), 2022

Research

Hashimoto's thyroiditis- What's in a name?

Hormones (Athens, Greece), 2025

Research

Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.

Best practice & research. Clinical endocrinology & metabolism, 2019

Guideline

Autoimmune Thyroiditis Causes and Associations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Autoimmune Conditions Associated with Hashimoto's Thyroiditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.